Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02540824 | Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT02321293 | A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC(CURCUMIN) | unknown | Phase 1 | 20 | Lady Davis InstituteOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02538380 | EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients | unknown | N/A | 40 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02535507 | Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 28, 2015 | clinicaltrials |
| NCT01914120 | the Quality of Life Assessment of Lung Cancer Patients in China | unknown | — | 3,000 | Sun Yat-sen UniversityOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT02283021 | Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC) | unknown | — | 200 | Hadassah Medical OrganizationOTHER | 0 | Aug 20, 2015 | clinicaltrials |
| NCT01592617 | Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer | unknown | Phase 2 | 45 | Shiga UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02518802 | Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 3 | 220 | Tang-Du HospitalOTHER | 1 | Aug 10, 2015 | clinicaltrials |
| NCT02513355 | Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research | unknown | Phase 4 | 400 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 4, 2015 | clinicaltrials |
| NCT01998425 | Circulating Fibrocytes in Non-small Cell Lung Cancer. | unknown | — | 60 | Chang Gung Memorial HospitalOTHER | 1 | Jul 31, 2015 | clinicaltrials |
| NCT02504801 | Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD | unknown | Phase 4 | 73 | Xiuyi ZhiOTHER | 0 | Jul 22, 2015 | clinicaltrials |
| NCT01843647 | Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients | unknown | Phase 2 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT01926171 | Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases | unknown | Phase 4 | 80 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02062515 | Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02497586 | Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer(MRS) | unknown | N/A | 15 | NHS Greater Glasgow and ClydeOTHER | 0 | Jul 14, 2015 | clinicaltrials |
| NCT02006043 | Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) | unknown | Phase 2 | 54 | Li ZhangOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT02393664 | Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection | unknown | Phase 2 / Phase 3 | 300 | National Taiwan University HospitalOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT02481661 | Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC | unknown | Phase 3 | 610 | Zhejiang Cancer HospitalOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT02469493 | The Effect and Mechanism of Electroacupuncture on Acute Chemotherapy-induced Nausea and Vomiting | unknown | N/A | 160 | Xidian UniversityOTHER | 1 | Jun 22, 2015 | clinicaltrials |
| NCT01172925 | Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer(TIDAL) | unknown | Phase 2 | 34 | Hamilton Health Sciences CorporationOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01929200 | Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02027090 | High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease | unknown | Phase 2 | 64 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02437760 | The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring | unknown | — | 200 | E-DA HospitalOTHER | 1 | May 8, 2015 | clinicaltrials |
| NCT02132143 | Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 | unknown | N/A | 60 | Hui LinOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02430974 | Chemotherapy of NSCLC With or Without Icotinib | unknown | Phase 2 | 50 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2015 | clinicaltrials |
| NCT02155426 | Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy | unknown | — | 1,200 | Sun Yat-sen UniversityOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT01914263 | Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection | unknown | Phase 1 | 40 | Alliancells-PuRui Biocience Co., Ltd.INDUSTRY | 1 | Apr 16, 2015 | clinicaltrials |
| NCT01772732 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC | unknown | Phase 1 | 30 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 9, 2015 | clinicaltrials |
| NCT02407600 | Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy | unknown | Phase 2 | 150 | Ajeet GajraOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02407366 | Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 80 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Apr 2, 2015 | clinicaltrials |
| NCT02399566 | Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma | unknown | Phase 4 | 300 | Hunan Province Tumor HospitalOTHER | 0 | Mar 26, 2015 | clinicaltrials |
| NCT01549093 | Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 90 | Hunan Province Tumor HospitalOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02375022 | Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations | unknown | Phase 2 | 10 | Zhejiang UniversityOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02066870 | Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI | unknown | Phase 1 | 9 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT02009605 | Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02363101 | Health Outcomes and Costs (HOC) in Lung Cancer (LC)(HOC-LC) | unknown | — | 300 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Mar 4, 2015 | clinicaltrials |
| NCT02140333 | Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC | unknown | Phase 3 | 220 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02362204 | Lung Cancer Nurse Model: a Phase II Study(LCN-II) | unknown | — | 71 | University of FreiburgOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02123888 | Simultaneous CBCT Acquisition During Arc Radiotherapy(SCART) | unknown | N/A | 75 | Sally FalkOTHER | 1 | Feb 9, 2015 | clinicaltrials |
| NCT02076282 | MRI Optimization Study in Stage III NSCLC | unknown | — | 30 | UMC UtrechtOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02350361 | Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. | unknown | Phase 2 / Phase 3 | 60 | Peking University Third HospitalOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT01337037 | Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC) | unknown | — | 1,000 | Peking University People's HospitalOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT01707888 | VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer | unknown | — | 500 | Peking University People's HospitalOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01690390 | Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02324530 | Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy | unknown | Phase 2 | 30 | Sheba Medical CenterOTHER_GOV | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01763385 | Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases(TRACTS) | unknown | Phase 2 | 210 | Wu Jieping Medical FoundationOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02320617 | Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer | unknown | N/A | 80 | Air Force Military Medical University, ChinaOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02185495 | Screening for Early Lung Cancer in Shanghai, China | unknown | Phase 2 | 3,000 | Shanghai Changzheng HospitalOTHER | 1 | Dec 18, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Sep 4, 2015source: clinicaltrials